                         SEQUENCE LISTING

<110>  BP Asset V, Inc.
 
<120>  FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS

<130>  B1539.70008WO00

<140>  PCT/US2021/025382
<141>  2021-04-01

<150>  US 63/004,365
<151>  2020-04-02

<150>  US 63/013,382
<151>  2020-04-21

<150>  US 63/156,058
<151>  2021-03-03

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by Decanoyl

<220>
<221>  Misc_feature
<222>  (4)..(4)
<223>  May be modified by CMK

<400>  1

Arg Val Lys Arg 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by pIRES

<220>
<221>  Misc_feature
<222>  (4)..(4)
<223>  May be modified by vector V5

<400>  2

Glu Gly Phe Pro 
1               


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by FAM

<220>
<221>  Misc_feature
<222>  (11)..(11)
<223>  May be modified by TAMRA

<400>  3

Gln Arg Val Arg Arg Ala Val Gly Ile Asp Lys 
1               5                   10      


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by GalNAc-T2

<400>  4

Gly Gly Gly Gly Ser Asp Ser Thr Ala Arg Ile Arg Arg 
1               5                   10              


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (9)..(9)
<223>  May be modified by GFP

<400>  5

Asn Ala Lys Gly Gly Gly Gly Gly Ser 
1               5                   


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by DABSYL/Glu

<400>  6

Thr Asn Ser Pro Arg Arg Ala Arg 
1               5               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (4)..(4)
<223>  May be modified by EDANS

<400>  7

Ser Val Ala Ser 
1               


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8

Tyr His Thr Val Ser Leu Leu Arg 
1               5               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9

Ser Thr Ser Gln 
1               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10

Thr Leu Thr Pro Arg Ser Val Arg 
1               5               


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11

Ser Val Pro Gly 
1               


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12

Thr Asn Ser Pro Arg Arg Ala Ala Ser Val Ala Ser 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  13

Thr Asn Ser Pro Ala Arg Ala Ala Ser Val Ala Ser 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  14

Thr Asn Ser Pro Ala Arg Ala Arg Ser Val Ala Ser 
1               5                   10          


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  15

Gly Ser Arg Ser Ala Arg 
1               5       


<210>  16
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  16

Ser Ala Ile Glu 
1               


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  17

Ser Lys Pro Ser Lys Arg 
1               5       


<210>  18
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  18

Ser Phe Ile Glu 
1               


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  19

Pro Arg Arg Ala Ala 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  20

Pro Ala Arg Ala Arg 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  21

Pro Ala Arg Ala Ala 
1               5   


<210>  22
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  22

Arg Arg Ala Arg 
1               


<210>  23
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  23

Arg Arg Ala Ala 
1               


<210>  24
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  24

Ala Arg Ala Arg 
1               


<210>  25
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  25

Ala Arg Ala Ala 
1               


<210>  26
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  26

Pro Arg Arg Ala Arg 
1               5   


<210>  27
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  27

Arg Gln Ser Arg 
1               


<210>  28
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  May be modified by GalNAc-T2

<220>
<221>  Misc_feature
<222>  (22)..(22)
<223>  May be modified by GFP

<400>  28

Gly Gly Gly Gly Ser Asp Ser Thr Ala Arg Ile Arg Arg Asn Ala Lys 
1               5                   10                  15      


Gly Gly Gly Gly Gly Ser 
            20          


<210>  29
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  29

Lys Pro Ser Lys Arg 
1               5   


<210>  30
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  30

Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr 
1               5                   10          


<210>  31
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  31

Ala Val Ala Ser 
1               


